Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Cellular Intelligence licenses Novo’s shelved Parkinson’s cell therapy programme

Novo Nordisk shuttered its cell therapy unit in October 2025, with assets now moving to new hands.

Robert Barrie

News

Gilead posts positive Q1 buoyed by HIV drug growth

Annabel Kartal Allen

News

FDA locks down post-approval pregnancy safety data framework

Annabel Kartal Allen

Features

AI-guided labs are approaching full autonomy

Analyst Comment

Japan’s FY26 price revision expands G1 repricing and drives price reduction

News

Novo’s CEO champions “record-breaking start” for Wegovy pill in US market

News

GSK spends $1bn on rights to SiranBio’s metabolic oligonucleotide

News

Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn

Analysis

Features

Podcast: Autonomous labs redefine the role of biopharma researchers

Frankie Fattorini

Features

Non-viral gene therapies emerge as key players amid viral safety bottlenecks

Annabel Kartal Allen

Analyst Comment

Thinning revenues: inside the $14bn Eliquis patent cliff

GlobalData Healthcare

Features

EU’s Joint Clinical Assessment system still finding its footing

Jam Bensilum

Themes

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Strong systems that enable trust and governance are key to enabling the growth of AI technologies in drug development.

More themes

Partner Content

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

News

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer

Partner Content

Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Q1 2026 CRO Activity and Intel Report

$1870.00

Bio/Pharmaceutical Outsourcing Report, April 2026

$2950.00

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Conference Highlights

$3750.00

Asthma: Global Clinical Trials Review, 2026

$3450.00

Rheumatic Disorders: Global Clinical Trials Review, 2026

$3450.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Gilead posts positive Q1 buoyed by HIV drug growth

FDA locks down post-approval pregnancy safety data framework

AI-guided labs are approaching full autonomy

Japan’s FY26 price revision expands G1 repricing and drives price reduction

Novo’s CEO champions “record-breaking start” for Wegovy pill in US market

GSK spends $1bn on rights to SiranBio’s metabolic oligonucleotide

Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn

Podcast: Autonomous labs redefine the role of biopharma researchers

Non-viral gene therapies emerge as key players amid viral safety bottlenecks

Thinning revenues: inside the $14bn Eliquis patent cliff

EU’s Joint Clinical Assessment system still finding its footing

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Q1 2026 CRO Activity and Intel Report

Bio/Pharmaceutical Outsourcing Report, April 2026

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Conference Highlights

Asthma: Global Clinical Trials Review, 2026

Rheumatic Disorders: Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Q1 2026 CRO Activity and Intel Report

Bio/Pharmaceutical Outsourcing Report, April 2026

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Conference Highlights

Asthma: Global Clinical Trials Review, 2026

Rheumatic Disorders: Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing